Bioneer owns a portfolio of patents and patent applications related to SAMiRNA technology, RNAi drugs/molecules for particular disease indications, and robust siRNA design algorithms. Bioneer's SAMiRNA core technology is protected within an extensive global intellectual property portfolio comprised of more than 40 patent applications and issued patents.

Patent table

Filing Date	Application No.	Date of Patent	Patent No.	Title	Country
2005-10-26	10-2005-101375	2008-07-21	848665	siRNA for Inhibiting Survivin Gene Expression	KR
2005-12-08	PCT/KR2005/004207			Method of Inhibiting Expression of Target mRNA Using siRNA Consisting of Nucleotide Sequence Complementary to Said Target mRNA	US, JP, EP
2007-06-05	10-2007-7012736	2011-01-04	1007346	Method of Inhibiting Expression of Target mRNA Using siRNA Consisting of Nucleotide Sequence Complementary to Said Target mRNA	KR
2007-08-07	200580047832.8	2010-12-15	ZL2005800 47832.8	Method of Inhibiting Expression of Target mRNA Using siRNA Consisting of Nucleotide Sequence Complementary to Said Target mRNA	CN
2007-03-19	10-2007-7006266	2008-07-21	848666	siRNA for Inhibiting NF-kB/RelA Expression	KR
2006-06-13	10-2006-052904	2008-01-08	794705	Method of Inhibiting Expression of Target mRNA Using siRNA Considering Alternative Splicing of Genes	KR
2007-06-12	12/304707			Method of preparing siRNAs for selective inhibition of target mRNA isotypes	US
2006-08-17	PCT/KR2006/003229			siRNA-HYDROPHILIC POLYMER CONJUGATES FOR INTRACELLULAR DELIVERY OF siRNA AND METHOD THEREOF	EP, AU, CA, CN, JP, IN, US
2006-12-05	10-2006-7025591	2009-02-05	883471	siRNA-HYDROPHILIC POLYMER CONJUGATES FOR INTRACELLULAR DELIVERY OF siRNA AND METHOD THEREOF	KR
2006-08-07	10/551466			Conjugate for gene transfer comprising oligonucleotide and hydrophilic polymer, polyelectrolyte complex micelles formed from the conjugate, and methods for preparation thereof	US
2008-01-23	10-2008-007032			An Anticancer Agent Comprising Double-Stranded miRNAs As An Active Ingredient	KR
2010-02-19	PCT/KR2010/001031			SiRNAs binding to apoptosis related gene transcripts and the composition for cancer treatment using them	KR, PCT
2010-05-13	PCT/KR2010/003039			siRNA conjugate and preparing method thereof	KR, AU, CA, CN, EP, JP, US, BR, IN, RU
2008-08-16	PCT/kr2008/003385			Gold-coated stent coated/plated the chemicals and oligo nucleotide binding gold-coated stent and process for producing the same	US, EP, JP, CN
2007-06-19	10-2007-059828	2011-03-10	1023164	Gold-coated stent coated/plated the chemicals and oligo nucleotide binding gold-coated stent and process for producing the same	KR
2011-12-15	10-2011-0135162			Stable antisense oligonucleotide conjugate and its manufacturing method	KR
2012-01-05	10-2012-0001710			Double-stranded oligo RNA molecule with a targeting ligand and method of preparing the same	KR
2012-01-05	10-2012-0001711			Nanoparticular double-stranded oligo RNA molecule with high efficacy and method of preparing the same	KR